Flow Electroporation for Vaccine Development and Production: From Subunit Vaccines to Ex Vivo Immunotherapy

BPI Contributor

June 1, 2014

1 Min Read
Flow Electroporation for Vaccine Development and Production: From Subunit Vaccines to Ex Vivo Immunotherapy

Already have an account?

MaxCyte flow electroporation is a universal, clinically validated transient transfection platform for rapid, high-quality cell transfection in the development and production of vaccines and cellular immunotherapies.

You May Also Like